Feedback / Questions
fluticasone propionate controlled release (EP-104) - Eupraxia Pharma
https://www.morningstar.com/news/globe-newswire/9444168/eupraxia-pharmaceuticals-announces-sustained-positive-treatment-outcomes-in-patients-with-eosinophilic-esophagitis-eoe-after-nine-months-of-receiving-ep-104gi
May 5, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next